HRSA, Hospital Settle Lawsuit Over Termination from 340B

The hospital Insight Chicago and federal regulators have agreed to dismiss a case before a federal district court over the hospital's 340B eligibility.
A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Finance Committee Republicans Oppose CMS Plan to Redefine Medicaid Best Price

Senate Finance Committee
A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.
A group of Senate Republicans recently urged federal regulators to withdraw a plan to change the definition of a drug’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Pushes Federal Court to Block Louisiana’s 340B Contract Pharmacy Law Without Trial

Louisiana capitol
PhRMA has asked a federal district judge to block Louisiana's 340B contract pharmacy law, Act 358, which took effect Aug. 1.
An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Urges Federal Court to Reject Novo Nordisk’s Challenge to 340B Contract Pharmacy Law

All drugmaker suits against Arkansas Act 1103 in federal district court should appear before Judge Billy Roy Wilson, AID said in a recent filing.
The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Federal Judge Rebukes HRSA on 340B Patient Definition

Genesis
Genesis Health Care successfully challenged HRSA's 340B patient definition in the U.S. District Court for the District of South Carolina.
A federal district judge in South Carolina late today struck down the 340B program’s patient definition, as federal regulators described [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Medicare to Continue ASP Plus 6% for 340B Drugs in 2024

CMS
In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.
Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Finalizes 340B Lump Sum Payment, Retains Offsetting Cuts Starting in 2026

CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Systems Sue to Reverse Elimination of Hospital Registration Waiver

U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
Forty-four health systems and hospitals sued federal healthcare agencies over their recent decision to end a 340B COVID-related registration flexibility [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sixth Drugmaker Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

Drugmaker Organon has loosened its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Upcoming DIR Fee Changes and Their Potential Impact on 340B Programs

SPONSORED CONTENT

The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that goes into effect on January 1, 2024 that changes the way Direct and Indirect Remuneration (DIR) fees are collected. To understand the impact

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live